# Gladstone Capital Corp: financial statements, quarterly

GLAD · Nasdaq · CIK 1143513 · [Other](/sectors/other.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/glad.md) · [Financials](/companies/glad/financials.md) · [Filings](/companies/glad/filings.md) · [Insiders](/companies/glad/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/glad/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [13.1 d](/filings/0001143513-25-000015.md) | [20.0](/filings/0001143513-25-000005.md) | [23.6](/filings/0001143513-25-000008.md) | [19.1](/filings/0001143513-25-000012.md) | [31.8 d](/filings/0001143513-25-000015.md) | [27.0](/filings/0001143513-26-000004.md) | [8.8](/filings/0001143513-26-000009.md) | [7.4](/filings/0001143513-26-000012.md) | [14.0 d](/filings/0001143513-25-000015.md) | [5.5](/filings/0001143513-26-000004.md) | [15.5](/filings/0001143513-26-000009.md) | [13.3](/filings/0001143513-26-000012.md) |
| Diluted EPS | $ per share | not reported | [0.55](/filings/0001143513-25-000005.md) | [0.49](/filings/0001143513-25-000008.md) | [0.57](/filings/0001143513-24-000008.md) | not reported | [0.50](/filings/0001143513-25-000005.md) | [0.50](/filings/0001143513-25-000008.md) | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | [0.55](/filings/0001143513-25-000005.md) | [0.49](/filings/0001143513-25-000008.md) | [0.57](/filings/0001143513-24-000008.md) | not reported | [0.50](/filings/0001143513-25-000005.md) | [0.50](/filings/0001143513-25-000008.md) | not reported | not reported | not reported | not reported | not reported |

- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.3](/filings/0001143513-24-000011.md) | [1.5](/filings/0001143513-24-000002.md) | [5.3](/filings/0001143513-24-000006.md) | [1.1](/filings/0001143513-24-000008.md) | [2.2](/filings/0001143513-25-000012.md) | [1.7](/filings/0001143513-25-000005.md) | [2.6](/filings/0001143513-25-000008.md) | [15.2](/filings/0001143513-25-000012.md) | [0.6](/filings/0001143513-26-000012.md) | [2.9](/filings/0001143513-26-000004.md) | [0.2](/filings/0001143513-26-000009.md) | [0.2](/filings/0001143513-26-000012.md) |
| Total assets | $m | [719](/filings/0001143513-24-000011.md) | [767](/filings/0001143513-24-000002.md) | [812](/filings/0001143513-24-000006.md) | [775](/filings/0001143513-24-000008.md) | [812](/filings/0001143513-25-000015.md) | [816](/filings/0001143513-25-000005.md) | [777](/filings/0001143513-25-000008.md) | [780](/filings/0001143513-25-000012.md) | [908](/filings/0001143513-26-000012.md) | [923](/filings/0001143513-26-000004.md) | [925](/filings/0001143513-26-000009.md) | [970](/filings/0001143513-26-000012.md) |
| Total liabilities | $m | [311](/filings/0001143513-24-000011.md) | [349](/filings/0001143513-24-000002.md) | [380](/filings/0001143513-24-000006.md) | [330](/filings/0001143513-24-000008.md) | [334](/filings/0001143513-25-000015.md) | [325](/filings/0001143513-25-000005.md) | [287](/filings/0001143513-25-000008.md) | [291](/filings/0001143513-25-000012.md) | [406](/filings/0001143513-26-000012.md) | [416](/filings/0001143513-26-000004.md) | [407](/filings/0001143513-26-000009.md) | [439](/filings/0001143513-26-000012.md) |
| Shareholders' equity | $m | [409](/filings/0001143513-25-000015.md) | [418](/filings/0001143513-25-000012.md) | [431](/filings/0001143513-25-000012.md) | [439](/filings/0001143513-25-000012.md) | [471](/filings/0001143513-26-000012.md) | [480](/filings/0001143513-26-000012.md) | [478](/filings/0001143513-26-000012.md) | [474](/filings/0001143513-26-000012.md) | [482](/filings/0001143513-26-000012.md) | [477](/filings/0001143513-26-000012.md) | [483](/filings/0001143513-26-000012.md) | [486](/filings/0001143513-26-000012.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [22.9 d](/filings/0001143513-25-000015.md) | [(26.2)](/filings/0001143513-25-000005.md) | [(19.1) d](/filings/0001143513-25-000008.md) | [54.2 d](/filings/0001143513-25-000012.md) | [(5.7) d](/filings/0001143513-25-000015.md) | [24.0](/filings/0001143513-26-000004.md) | [46.8 d](/filings/0001143513-26-000009.md) | [20.4 d](/filings/0001143513-26-000012.md) | [(96.6) d](/filings/0001143513-25-000015.md) | [(33.8)](/filings/0001143513-26-000004.md) | [16.6 d](/filings/0001143513-26-000009.md) | [(36.9) d](/filings/0001143513-26-000012.md) |
| Dividends paid | $m | [10.7 d](/filings/0001143513-25-000015.md) | [10.8](/filings/0001143513-25-000005.md) | [10.8 d](/filings/0001143513-25-000008.md) | [10.8 d](/filings/0001143513-25-000012.md) | [10.8 d](/filings/0001143513-25-000015.md) | [20.0](/filings/0001143513-26-000004.md) | [11.1 d](/filings/0001143513-26-000009.md) | [11.1 d](/filings/0001143513-26-000012.md) | [13.4 d](/filings/0001143513-25-000015.md) | [10.2](/filings/0001143513-26-000004.md) | [10.2 d](/filings/0001143513-26-000009.md) | [10.2 d](/filings/0001143513-26-000012.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [35.2](/filings/0001143513-24-000002.md) | [36.6](/filings/0001143513-24-000006.md) | [18.8](/filings/0001143513-24-000008.md) | [21.8](/filings/0001143513-25-000005.md) | [21.8](/filings/0001143513-25-000008.md) | [21.8](/filings/0001143513-25-000012.md) | [22.3](/filings/0001143513-26-000004.md) | [22.3](/filings/0001143513-26-000009.md) | [22.3](/filings/0001143513-26-000012.md) | [28.4](/filings/0001143513-26-000004.md) | [28.4](/filings/0001143513-26-000009.md) | [28.4](/filings/0001143513-26-000012.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 22,593,069 at 2026-08-03, from the cover of the [10-Q filed 2026-08-04](/filings/0001143513-26-000012.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.